X-Chem

X-Chem is a biotechnology company that utilizes DNA-encoded drug discovery engine for the generation of novel-based small molecule therapeutics. Read more

Matthew Clark's photo - CEO of X-Chem

CEO

Matthew Clark

CEO Approval Rating

90/100

X-CHEM TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Rigel Pharmaceuticals is X-Chem's biggest rival. Rigel Pharmaceuticals was founded in 1996, and is headquartered in South San Francisco, California. Rigel Pharmaceuticals competes in the Pharmaceuticals industry. Rigel Pharmaceuticals generates $121.4M more revenue vs. X-Chem.

Vividion is one of X-Chem's top competitors. Vividion's headquarters is in San Diego, California, and was founded in 2014. Vividion operates in the Biotechnology industry. Vividion generates 81% of X-Chem's revenue.

Crinetics is seen as one of X-Chem's top competitors. Crinetics is a Public company that was founded in 2008 in San Diego, California. Crinetics is in the Biotechnology field. Compared to X-Chem, Crinetics has 63 more employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is BioInvent a competitor of X-Chem?

X-Chem Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
AviSyn

Jan 2021

Source »
undisclosed
Envision is a Canada-based drug discovery company that provides development programs for clinically viable and risk-free drug candidates.

These are all the companies that X-Chem has acquired. X-Chem's latest acquisition was AviSyn in Jan 2021. Envision is a Canada-based drug discovery company that provides development programs for clinically viable and risk-free drug candidates.

X-Chem Funding History

No recent funding data found related to X-Chem

X-Chem Investments

No recent investments found related to X-Chem

These are all the companies that X-Chem has invested in. X-Chem's latest investment was AviSyn in Jan 2021. Envision is a Canada-based drug discovery company that provides development programs for clinically viable and risk-free drug candidates.

X-Chem News

January 26, 2021Contract Pharma

X-Chem Acquires IntelliSyn and AviSyn

Acquisitions allow the company to offer services for screening, hit validation and lead optimization ... See more »
January 7, 2021Contract Pharma

Servier and X-Chem Enter Drug Discovery Collaboration

Partner to identify and develop novel small molecules for the treatment of neurological disorders.... See more »
October 1, 2020BioSpace

Proteros Biostructures and X-Chem to Offer Comprehensive Joint Target-to-Lead Drug Discovery Services

Proteros Biostructures GmbH (Proteros) and X-Chem, Inc. (X-Chem) announced today the launch of an all... See more »
July 22, 2020MarketScreener

X-Chem Announces Achievement of Milestone In Orexia Collaboration

(marketscreener.com) X-Chem, Inc. , the global leader in DNA-encoded small molecule library screening... See more »
June 11, 2020MarketScreener

Study Published in the Journal of Medicinal Chemistry Demonstrates the Power of Machine Learning to Unlock New Chemistry and Biology to Treat Disease

(marketscreener.com) -Largest Reported Prospective Study Applying Machine Learning for Small Molecule... See more »
June 10, 2020firstwordpharma

Study Published in the Journal of Medicinal Chemistry Demonstrates the Power of Machine Learning to Unlock New Chemistry and Biology to Treat Disease

WALTHAM, Mass.--(BUSINESS WIRE)-- X-Chem, Inc., the leader in DNA-encoded small molecule library scre... See more »
June 4, 2020Business Wire

X-Chem Matthew Clark joined as CEO

Upon completion of the transaction, Matt Clark, co-founder of X-Chem and current SVP of Chemistry wil... See more »

X-Chem Press Releases

January 9, 2015BUSINESS WIRE

X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases

WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. and Janssen Biotech, Inc. to collaborate on the discove... See more »
December 17, 2014BUSINESS WIRE

X-Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. licenses cardiovascular drug discovery program to Bayer... See more »
December 11, 2014BUSINESS WIRE

X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders

WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem to discover small molecule drug candidates for global develop... See more »
September 25, 2014BUSINESS WIRE

PPD Exercises Option to Acquire Remaining Interest in X-Chem, Inc.

WILMINGTON, N.C. & WALTHAM, Mass.--(BUSINESS WIRE)--PPD exercised its option to acquire the remaining... See more »
February 13, 2014BUSINESS WIRE

X-Chem Licenses Epigenetic Drug Discovery Program to Bayer Pharma AG

WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem Inc. announces license to Bayer Pharma AG for early-stage dru... See more »
February 4, 2014BUSINESS WIRE

X-Chem First Biotech to Exceed 100 Billion Compounds with its Unique and Proprietary Small Molecule DNA-Encoded Library

WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem Inc. publishes breakthrough DNA-encoding strategy in peer-rev... See more »

Social Media

X-Chem Headquarters

100 Beaver Street

Waltham, Massachusetts02453

781-419-6900

Driving Directions »

Trending Companies

X-Chem Summary

ABOUT

Overview

X-Chem is a biotechnology company that utilizes DNA-encoded drug discovery engine for the generation of novel-based small molecule therapeutics. X-Chem was founded in 2009. X-Chem's headquarters is located in Waltham, Massachusetts, USA 02453. X-Chem'...

CEO

X-Chem's CEO, Matthew Clark, currently has an approval rating of 90%. X-Chem's primary competitors are Rigel Pharmaceuticals, Vividion & Crinetics.

Frequently Asked Questions about X-Chem

  1. When was X-Chem founded?

    X-Chem was founded in 2009
  2. Who is X-Chem's CEO?

    X-Chem's CEO is Matthew Clark
  3. How much revenue does X-Chem generate?

    X-Chem generates $12.5M in revenue
  4. How much funding does X-Chem have?

    X-Chem has historically raised $0 in funding
  1. Where is X-Chem's headquarters?

    X-Chem's headquarters is in Waltham Massachusetts, USA
  2. How many employees does X-Chem have?

    X-Chem has 30 employees
  3. What sector does X-Chem operate in?

    X-Chem is in Medical Research & Laboratories
  4. Who are X-Chem's competitors?

    X-Chem's top competitors are Rigel Pharmaceuticals, Vividion, Crinetics